Vice President CGT & API Global Expansion
Eli Lilly
Senior Vice President Manufacturing & Technical Operations
Lantheus
Robert T. Haslam Professor of Chemical Engineering, Emeritus, and Faculty Director, Emeritus Deshpande Center for Technological Innovation
MIT
VP CMC
Pioneering Medicines / Flagship Pioneering
Head of Alliances, Manufacturing & Supply - Specialty Care
Sanofi
Robert T. Haslam Professor of Chemical Engineering, Emeritus, and Faculty Director, Emeritus Deshpande Center for Technological Innovation
MIT
Robert T. Haslam Professor of Chemical Engineering, Emeritus, and Faculty Director, Emeritus Deshpande Center for Technological Innovation
MIT
Executive Vice President, Global Operations & Information Technology
AstraZeneca
Executive Vice President, Global Quality
Eli Lilly
• Quality as a business driver by “Flipping the Ratio”
• Transforming business growth through Proactive Quality
• Preparing our organization for the future of Quality Assurance
Project Farma
Senior Director of Product
MasterControl, Inc.
Boehringer Ingelheim
These mutually agreed-upon conversations are arranged and facilitated by Executive Platforms staff to ensure attendees have valuable discussions about their top-of-mind questions, challenges, and opportunities.
Chief Technical Officer
Abata Therapeutics
Vice President Quality Assurance
Ultragenyx
Vice President, Global Clinical Supply Chain
Gilead Sciences
Exec. Director
AstraZeneca
Executive Director, New Modalities and Platform Technology, Global Technical Operations
AstraZeneca
GPS Digital Transformation Lead
Bristol Myers Squibb
Director, Global Supplier Quality Management
Gilead
AVP Small Molecule Manufacturing
Merck
Executive Director, R&D Operations and Quality
Neuraly
PA Consulting Group Inc.
Redaptive
AVP, Global Head Connected Smart Factories, Manufacturing & Supply
Sanofi
Sr. Director External Manufacturing
Verve Therapeutics
Honeywell Life Sciences
Axplora
These mutually agreed-upon conversations are arranged and facilitated by Executive Platforms staff to ensure attendees have valuable discussions about their top-of-mind questions, challenges, and opportunities.
Senior Science Advisor/CMC Lead
FDA
Chief Quality Officer
Biogen
Robert T. Haslam Professor of Chemical Engineering, Emeritus, and Faculty Director, Emeritus Deshpande Center for Technological Innovation
MIT
Robert T. Haslam Professor of Chemical Engineering, Emeritus, and Faculty Director, Emeritus Deshpande Center for Technological Innovation
MIT
Robert T. Haslam Professor of Chemical Engineering, Emeritus, and Faculty Director, Emeritus Deshpande Center for Technological Innovation
MIT
Senior Vice President Global Manufacturing
Amgen
Chief Technical Operations & Quality Officer
Moderna
Executive Vice President, Chief Technical Operations Officer
Sarepta Therapeutics
Senior Vice President, Head Global Quality Compliance & Systems
Takeda
Global Quality Takeda is reimagining their quality commitments across the value chain. By harnessing data, digital, and emerging technologies like AI, they aim to accelerate product delivery, foster a culture of learning and innovation, and ensure environmental sustainability. They are simplifying, standardizing, and digitalizing quality processes with increased automation and AI, demonstrated through case studies such as one-day batch release, investigation reports, and APQRs. These examples highlight how AI can enable sustainable quality transformation.
Chief Patient Supply Officer
Spark Therapeutics
These mutually agreed-upon conversations are arranged and facilitated by Executive Platforms staff to ensure attendees have valuable discussions about their top-of-mind questions, challenges, and opportunities.
Head of Process Monitoring & Data Science/AI Strategy
Sanofi
INCOG BioPharma Services, Inc.
Senior Vice President, Global Supply Chain
Bristol Myers Squibb
Vice President Global Supply Chain
BioMarin
Executive Vice President Supply Chain & Operations
Kyowa Kirin
Executive Director, Technical Operations
AstraZeneca
Chief Technical Operations & Quality Officer
Alnylam Pharmaceuticals
When all others said ‘impossible’, Alnylam turned the promise of RNAi into a proven new class of medicines and is at an inflection point to launch a blockbuster medicine. Alnylam has ambitions to address some of the world’s most prevalent diseases. Success is dependent upon fueling the potential of a deep pipeline of clinical and commercial-stage assets. The problem is, How? The answer goes beyond R&D and Commercial capabilities. As Chief of Technical Operational and Quality, Tim Maines has the experience and mindset to scale for the opportunities ahead for siRNA-based medicines and beyond. This session will discuss how to elevate manufacturing innovation as instrumental for helping the most patients by enabling companies to be big and small at the same time.
Robert T. Haslam Professor of Chemical Engineering, Emeritus, and Faculty Director, Emeritus Deshpande Center for Technological Innovation
MIT